section name header

Information

is created by a controlled thaw of frozen plasma that allows for precipitation of large molecules. It is then centrifuged with the final product containing fibrinogen, fibronectin, vWF, factor VIII, and factor XIII (1 unit of plasma typically generates 10–20 mL of cryoprecipitate) (Table 16-9: Indications for the use of Cryoprecipitate).

Outline

Hemostasis and Transfusion Medicine

  1. Hemostasis and Coagulation
  2. Fibrinolysis
  3. Laboratory Evaluation of Hemostasis
  4. Laboratory Evaluation of Primary Hemostasis
  5. Laboratory Evaluation of Secondary Hemostasis and Coagulation
  6. Diagnosis of Thromboembolic Disorders
  7. Monitoring Anticoagulation Therapeutic Agents
  8. Blood Component Production
  9. Blood Products and Transfusion Thresholds
  10. Physiologic Compensation for Anemia
  11. Platelets
  12. Fresh Frozen Plasma
  13. Cryoprecipitate
  14. The Risks of Blood Product Administration
  15. Blood Conservation Strategies
  16. Disorders of Hemostasis: Diagnosis and Treatment
  17. Anticoagulation and Pharmacologic Therapy
  18. Prothrombin Complex Concentrates
  19. Desmopressin
  20. Antifibrinolytic Therapy